| Responsibilities of the Board |
| |
Board Composition
|
| |
a. |
Ex-Officio |
| |
|
|
Alfredo E. Pascual |
|
|
|
: |
Chairman |
| |
|
|
|
|
|
|
|
Secretary – Department of Trade & Industry |
| Members |
| |
|
|
Antonilo D. Mauricio |
|
|
|
: |
General Manager – National Development Company |
| |
|
|
Dante O. Tinga |
|
|
|
: |
Chair – Development Bank of the Philippines |
| |
|
|
Ceferino S. Rodolfo |
|
|
|
: |
Undersecretary – Board of Investments, DTI |
| |
|
|
Ma. Antonia Yulo-Loyzaga |
|
|
|
: |
Secretary – Dept of Environment and Natural Resources |
| |
|
|
Arsenio M. Balisacan |
|
|
|
: |
Secretary – National Economic Development Authority |
| |
|
|
Ferdinand R. Marcos, Jr. |
|
|
|
: |
President / Secretary – Department of Agriculture |
| |
|
| |
b. |
Appointive (please provide location of information on position in other GOCCs and PLCs) |
| |
|
|
Usec. Emmie Liza Perez-Chiong, DMD |
: |
Vice-Chair |
| |
|
|
|
|
|
|
|
President and CEO – PITC |
| |
|
|
Atty. Antonio C. Lopez Jr. |
| |
|
|
|
| |
Approved schedules of board meetings (please include when the schedule was approved) |
| |
|
| |
Role of the board in corporate strategy |
| |
|
How does the board overseas the implementation of the corporate strategy |
| |
|
When did the board review the corporate strategy? |
| |
|
|
|
| |
Code of Ethics |
| |
|
|
|
| |
Board Committees’ Accomplishment Report |
| |
|
| |
Board of Directors - Minutes of the Meeting |
| |
|
|
|
| |
Access to information (board materials) |
| |
|
|
|
| |
Internal Control (including Internal Audit) |
| |
|
|
|
| |
Risk Management System |
| |
|
|
|
| |
Board Appraisal System |
| |
a. |
Criteria |
| |
b. |
Procedure |
| |
|
|
|
| |
Corporate Secretary |
| |
|
|
|
| Disclosure and Transparency (at least 2013 – present disclosures) |
| |
Certificate – Payment of Statutory Obligation |
| |
a. |
Pag-ibig |
| |
b. |
PhilHealth |
| |
c. |
GSIS |
| |
|
| |
Declaration and Payment of Dividends |
| |
a. |
2021 |
| |
b. |
2020 |
| |
c. |
2019 |
| |
d. |
2018 |
| |
e. |
2017 |
| |
f. |
2016 |
| |
g. |
2015 |
| |
h. |
2014 |
| |
|
|
|
| |
Action Plan on COA AOM |
| |
a. |
2022 |
| |
b. |
2021 |
| |
c. |
2020 |
| |
d. |
2019 |
| |
e. |
2018 |
| |
f. |
2017 |
| |
g. |
2016 |
| |
h. |
2015 |
| |
i. |
2014 |
| |
|
|
| |
2023 PITC Tax Clearance |
| |
2022 PITC Tax Clearance |
| |
2021 PITC Tax Clearance |
| |
2020 PITC Tax Clearance |
| |
2019 PITC Tax Clearance |
| |
2018 PITC Tax Clearance |
| |
2017 PITC Tax Clearance |
| |
|
|
|
| |
Report on Ageing of Cash Advance as of June 2017 |
| |
Report on Ageing of Cash Advance as of 15 November 2018 |
| |
|
|
|
| |
PITC PhilGEPS Platinum Certificate
|
| |
|
|
|
| I. |
Institutional Matters |
| |
|
|
|
| |
a. |
PITC Charter |
| |
|
|
P.D. 1071 – Sections 1-18 |
| |
|
|
P.D. 1071 – Sections 19-32 |
| |
|
|
P.D. 1071 – By Laws |
| |
|
|
E.O. 756 |
| |
|
|
E.O. 877 |
| |
|
|
E.O. 1067 |
| |
|
|
Relevant Excerpt from EO No. 133 |
| |
|
|
Consolidated File of PITC Charter |
| |
|
|
|
| |
b. |
Latest General Information Sheet and brief company background including date of incorporation, history and functions and mandate – NOT APPLICABLE |
| |
|
|
|
| |
c. |
List of Subsidiaries and Affiliates |
| |
|
c.1 |
Philippine Pharma Procurement Inc. (PPPI) |
| |
|
c.2 |
Center for International Trade Expositions and Missions (CITEM) |
| |
|
|
|
| |
d. |
Government Corporate Information Sheet (GCIS) as mandated by the GCG in its Memorandum Circular No. 2012-01 |
| |
|
|
2022 |
| |
|
|
2021 |
| |
|
|
2020 |
| |
|
|
2019 |
| |
|
|
2018 |
| |
|
|
2017 |
| |
|
|
2016 |
| |
|
|
2015 |
| |
|
|
2014 |
| |
|
|
2013 |
| |
|
|
2012 |
| |
|
|
2011 |
| |
|
|
|
| II. |
On the Board and Officers |
| |
a. |
Complete Listing of the Directors and Officers with attached resume and their membership in Board Committees |
| |
|
|
Board of Directors |
| |
|
|
|
| |
|
|
PITC Officers |
| |
|
|
|
| |
b. |
Complete compensation package of all the board members and officers, including travel, representation, transportation and any other form of expenses or allowance |
| |
|
|
2022 |
| |
|
|
2021 |
| |
|
|
2020 |
| |
|
|
2019 |
| |
|
|
2018 |
| |
|
|
2017 |
| |
|
|
2016 |
| |
|
|
2015 |
| |
|
|
2014 |
| |
|
|
2013 |
| |
|
|
|
| |
c. |
Information on Board Committees and their activities |
| |
|
|
Meetings |
| |
|
|
Attendance |
| |
|
|
|
| |
d. |
Attendance Record of Directors in Board |
| |
|
|
2022 |
| |
|
|
2021 |
| |
|
|
2020 |
| |
|
|
2019 |
| |
|
|
2018 |
| |
|
|
2017 |
| |
|
|
2016 |
| |
|
|
2015 |
| |
|
|
2014 |
| |
|
|
2013 |
| |
|
|
2012 |
| |
|
|
|
| III. |
On Financial and Operation Matters |
| |
a. |
Latest Annual Audited Financial and Performance Report within thirty (30) days from receipt of such report |
| |
|
|
|
|
| |
|
Date Published |
Year of the Report |
Date Receipt from COA |
| |
|
9 June 2023
|
2022 |
06 June 2023
|
| |
|
|
|
|
| |
b. |
Audited Financial Statements in the immediate three (3) years |
| |
|
|
|
|
| |
|
Date Published |
Year of the Report |
Date Receipt from COA |
| |
|
07 July 2022 |
2021 |
10 June 2022 |
| |
|
30 July 2021 |
2020 |
23 July 2021 |
| |
|
09 September 2020 |
2019 |
09 September 2020 |
| |
|
08 May 2019 |
2018 |
03 May 2019 |
| |
|
01 June 2018 |
2017 |
23 May 2018 |
| |
|
22 May 2017 |
2016 |
19 May 2017 |
| |
|
08 June 2016 |
2015 |
06 June 2016 |
| |
|
02 July 2015 |
2014 |
30 June 2015 |
| |
|
25 July 2014 |
2013 |
24 June 2014 |
| |
|
|
|
|
| |
c. |
Quarterly and Annual Report and Trial Balance |
| |
|
|
|
| |
|
|
|
| |
|
2023 |
|
| |
|
|
|
|
| |
|
1st Quarter Report |
Trial Balance |
|
| |
|
|
|
|
| |
|
2022 |
|
| |
|
|
|
|
| |
|
4th Quarter Report |
Trial Balance |
|
| |
|
3rd Quarter Report |
Trial Balance |
|
| |
|
2nd Quarter Report |
Trial Balance |
|
| |
|
1st Quarter Report |
Trial Balance |
|
| |
|
|
|
|
| |
|
2021 |
|
| |
|
4th Quarter Report |
Trial Balance |
|
| |
|
3rd Quarter Report |
Trial Balance |
|
| |
|
2nd Quarter Report |
Trial Balance |
|
| |
|
1st Quarter Report |
Trial Balance
|
|
| |
|
|
|
|
| |
|
2020 |
|
| |
|
4th Quarter Report |
Trial Balance |
|
| |
|
3rd Quarter Report |
Trial Balance |
|
| |
|
2nd Quarter Report |
Trial Balance |
|
| |
|
1st Quarter Report |
Trial Balance |
|
| |
|
|
|
|
| |
|
2019 |
|
| |
|
4th Quarter Report |
Trial Balance |
|
| |
|
3rd Quarter Report |
Trial Balance |
|
| |
|
2nd Quarter Report |
Trial Balance |
|
| |
|
1st Quarter Report |
Trial Balance |
|
| |
|
|
|
|
| |
|
2018 |
|
| |
|
4th Quarter Report |
Trial Balance |
|
| |
|
3rd Quarter Report |
Trial Balance |
|
| |
|
2nd Quarter Report |
Trial Balance |
|
| |
|
1st Quarter Report |
Trial Balance |
|
| |
|
|
|
|
| |
|
2017 |
|
| |
|
4th Quarter Report |
Trial Balance |
|
| |
|
3rd Quarter Report |
Trial Balance |
|
| |
|
2nd Quarter Report |
Trial Balance |
|
| |
|
1st Quarter Report |
Trial Balance |
|
| |
|
|
|
|
| |
|
2016 |
|
| |
|
4th Quarter Report |
Trial Balance |
|
| |
|
3rd Quarter Report |
Trial Balance |
|
| |
|
2nd Quarter Report |
Trial Balance |
|
| |
|
3rd Quarter Report |
Trial Balance |
|
| |
|
|
|
|
| |
|
2015 |
|
| |
|
4th Quarter Report |
Trial Balance |
|
| |
|
3rd Quarter Report |
Trial Balance |
|
| |
|
2nd Quarter Report |
Trial Balance |
|
| |
|
1st Quarter Report |
Trial Balance |
|
| |
|
|
|
|
| |
|
2014 |
|
| |
|
4th Quarter Report |
Trial Balance |
|
| |
|
3rd Quarter Report |
Trial Balance |
|
| |
|
2nd Quarter Report |
Trial Balance |
|
| |
|
1st Quarter Report |
Trial Balance |
|
| |
|
|
|
|
| |
|
2013 |
|
| |
|
4th Quarter Report |
|
|
| |
|
3rd Quarter Report |
Trial Balance |
|
| |
|
2nd Quarter Report |
Trial Balance |
|
| |
|
1st Quarter Report |
Trial Balance |
|
| |
|
|
|
|
| |
d. |
Current Corporate Operating Budget (COB) |
| |
|
d.1 |
2023 |
| |
|
d.2 |
2018 |
| |
|
d.3 |
2017 |
| |
|
d.4 |
2016 |
| |
|
d.5 |
2015 |
| |
|
d.6 |
2014 |
| |
|
d.7 |
2013 |
| |
|
d.8 |
2012 |
| |
e. |
Local and Foreign Borrowings |
| |
f. |
Government subsidies and net lending |
| |
g. |
Borrowings Guaranteed by the Government |
| |
h. |
Material Risk Factors and Measures to Manage such Risk
|
| |
i. |
Performance Evaluation System (PES) |
| |
|
|
| IV. |
On Governance Matters |
| |
a. |
Charter Statement / Mission – Vision Statements |
| |
b. |
2023 GCG Approved Performance Scorecard |
| |
|
2nd Quarter Performance Scorecard Report |
| |
|
1st Quarter Performance Scorecard Report |
| |
|
2022 GCG-Validated Performance Scorecard |
| |
|
2022 GCG Approved Performance Scorecard |
| |
|
4th Quarter Performance Scorecard Report |
| |
|
3rd Quarter Performance Scorecard Report |
| |
|
2nd Quarter Performance Scorecard Report |
| |
|
1st Quarter Performance Scorecard Report |
| |
|
2021 GCG-Validated Performance Scorecard |
| |
|
4th Quarter 2021 Performance Scorecard Report |
| |
|
2020 Performance Scorecard Report |
| |
|
Performance Scorecard and Strategy Map |
| |
|
GCG Validated 2019 Performance Scorecard Result |
| |
|
4th Quarter Performance Scorecard Report |
| |
|
3rd Quarter Performance Scorecard Report |
| |
|
2nd Quarter Performance Scorecard Report |
| |
|
1st Quarter Performance Scorecard Report |
| |
|
GCG Validated 2018 Performance Scorecard Result |
| |
|
2018 Performance Scorecard and Strategy Map |
| |
|
4th Quarter Performance Scorecard Report |
| |
|
3rd Quarter Performance Scorecard Report |
| |
|
2nd Quarter Performance Scorecard Report |
| |
|
1st Quarter Performance Scorecard Report |
| |
|
2017 Performance Scorecard and Strategy Map |
| |
|
4th Quarter Performance Scorecard Report |
| |
|
3rd Quarter Performance Scorecard Report |
| |
|
2nd Quarter Performance Scorecard Report |
| |
|
1st Quarter Performance Scorecard Report |
| |
|
2016 Performance Scorecard and Strategy Map |
| |
|
3rd Quarter Performance Scorecard Report |
| |
|
2nd Quarter Performance Scorecard Report |
| |
|
1st Quarter Performance Scorecard Report |
| |
|
2015 Performance Scorecard and Strategy Map |
| |
|
Annual Performance Scorecard Report |
| |
|
3rd Quarter Performance Scorecard Report |
| |
|
2nd Quarter Performance Scorecard Report |
| |
|
1st Quarter Performance Scorecard Report |
| |
|
|
| |
c. |
Organization Chart |
| |
d. |
Manual of Corporate Governance |
| |
e. |
Corporate Social Responsibility Statement |
| |
f. |
Balanced Scorecard |
| |
g. |
No Gift Policy and Statement |
| |
h. |
Code of Conduct for PITC Officers and Employees |
| |
i. |
Statement of No Audit Suspension – COA |
| |
j. |
Freedom of Information Manual |
| |
k. |
Signed performance scorecard for Performance Years 2013-2023 |
| |
|
2023 |
| |
|
2022 |
| |
|
2021 |
| |
|
2020 |
| |
|
2019 |
| |
|
2018 |
| |
|
2017 |
| |
|
2016 |
| |
|
2015 |
| |
|
2014 |
| |
|
2013 |
| |
l. |
Other Information or report the GCG may require |
| |
|
a. Copy of Compensation Plan (if SSL-exempt) in MS Excel and hard copy - Not Applicable |
| |
|
b. Copy of Organizational Structure and Staffing Pattern in both hard and soft copy |
| |
|
c. For non-chartered GOCCs; copy of the latest Articles of Incorporation (AOI) - Not Applicable |
| |
|
d. For non-chartered GOCCs; copy of the latest By-Laws - Not Applicable |
| |
|
|
| State the location of the following information in the annual report / audited annual financial report |
| |
- |
Corporate Objectives |
| |
- |
Financial Performance Indicators |
| |
- |
Non-Financial Performance Indicators |
| |
- |
Details of Whistle Blowing Policy |
| |
- |
Biographical Details (at least age, qualifications, date of first appointment, relevant experience, and any other directorships of listed companies) of directors/commissioners |
| |
- |
Training and/or continuing education programme attended by each director/commissioner |
| |
- |
Statement of Full Compliance with the Code of Corporate Governance – Certificate |
| |
- |
Review of the GOCC’s Material Controls (including operational, financial and compliance controls) and Risk Management Systems |
| |
- |
Statement from the Board of Directors or Audit Committee commenting on the adequacy of GOCC’s Internal Controls/Risk Management Systems |
| |
|
|
| Corporate Social Responsibility |
| |
Customers’ Welfare |
| |
|
|
| |
|
|
| |
|
|
| |
Interaction with the Communities |
| |
|
|
| |
|
|
| |
|
|
| |
Environmentally-friendly Value Chain |
| |
|
|
| |
|
|
| |
|
|
| |
Contact Details for Complaints of Other Stakeholders |
| |
|
|
| |
Employees’ Welfare and Development |
|
|
|
|
|
|
|
|
|
| |
|
|
